Categories: News

PMD Device Solutions Begins Preparation for First German Hospital Pilot

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

STOCKHOLM, SWEDEN / ACCESSWIRE / March 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) A leading 1,100-bed hospital in Bavaria commences IT governance ahead of their first patient use of RespiraSense in their 30-bed respiratory ward.

A leading 1,100-bed German clinic in the Bavarian region will pilot RespiraSense to address the clinical need for quality respiratory rate monitoring and improving outcomes of non-invasively ventilated patients. This pilot marks the start of PMDS’ German market access programme. The pilot process has begun with the review of PMDS’ IT (Information Technology) and clinical governance documentation, which will last between 2-3 weeks. After that, the clinical team can use RespiraSense on their first patient in a 30-bed general ward for patients admitted with respiratory compromise. The pilot is anticipated to last for a total of 4 weeks and to commence by late April 2024.

“Over the coming months, PMDS will increase its understanding of hopsital requirements to be able to sell in the German market successfully. Such elements include understanding the level of IT governance, clinical workflow, guidance, and the procurement process. These elements are required to ensure an efficient selling process is achieved in any new clinical pathway or geographical market. ” Says Myles Murray, Founder and CEO of PMDS.

This pilot marks the first of PMDS’ financial target to complete more than 10 pilots across the UK, German and US markets during 2024.

Information about PMDS

PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company’s knowledge, the world’s only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA cleared in the US. The company’s shares are listed on Nasdaq First North Growth Market (STO: PMDS).

For additional information, please contact

Myles Murray, CEO
Phone: +353 86 887 4994
E-mail: myles@pmd-solutions.com & for general enquiries investor.relations@pmd-solutions.com
The Company’s Certified Adviser is Redeye.

Attachments

PMD Device Solutions begins preparation for first German hospital pilot

SOURCE: PMD Device Solutions

View the original press release on accesswire.com

Staff

Recent Posts

NSCEB Announces Biotech Across America Roadshow, Makes First Stop in North Carolina

NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem  RALEIGH, N.C., June…

19 hours ago

NextGen Healthcare Welcomes Madison Dearborn Partners as New Investment Partner and Announces Planned Leadership Succession

MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo…

1 day ago

Rocketseed launches essential email signature guide for healthcare organizations

New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement…

1 day ago

Hospital PMI® at 52%; May 2025 Hospital ISM® Report On Business®

TEMPE, Ariz., June 6, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in…

1 day ago

Infisical Secures $16M Series A to Redefine Enterprise Secrets, Identity, and Access Management

Open-source leader democratizes enterprise-grade secrets management for fastest-growing startups, Fortune 500 enterprises, and nation-states. SAN…

1 day ago

Choctaw Nation and Healthy Together Launch Streamlined Summer EBT Program in Just Six Weeks

MIAMI, June 6, 2025 /PRNewswire/ -- Healthy Together, a leading provider of health and human…

1 day ago